The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
March 24th 2025
Microultrasonography-guided biopsy offered comparable detection as MRI/conventional ultrasound-guided biopsy in detection of Gleason grade group 2 or higher prostate cancer, according to a new international multicenter study.
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment
April 4, 2025 | New York, NY & Virtual
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
Radiologists can play central role in fetal MRI's bright future
May 15th 2006This month sees a clutch of national radiological congresses taking place. The annual U.K., German, and Spanish meetings are held during May, but a more specialized event looks set to attract considerable attention: the first International Congress on Fetal MRI, to be staged in Vienna from 12 to 13 May.
MR imaging illuminates elbow joint disorders
May 15th 2006The elbow is a complex joint. It links the shoulder and the hand, enhances the flexibility of hand motion, and transmits generated forces. The most common elbow injuries are related to chronic overuse, although the joint is vulnerable to acute trauma as well.1 It may also be affected by disease or infection.
Indications expand for fetal MR imaging
May 15th 2006Fetal MRI has become established in clinical practice over the past decade. MRI is indicated when conditions do not favor fetal ultrasound such as cases of maternal obesity or anhydramnios.1 It has also been shown that fetal MRI may discriminate among tissue components that do not display impedance differences on ultrasound; for instance, laminae in the developing brain.2 These advantages, along with MR's ability to delineate small structures, such as cranial nerves, has furthered its use as an adjunct to ultrasound in fetal imaging.1 Applications for fetal MRI are growing. The development of improved methods for fetal imaging, including availability of ultrafast sequences,3 has also furthered adoption.
Biomedical research in Oregon gets boost from 12T MR scanner
May 12th 2006A new 12-ton, 12T MR scanner will help researchers in Oregon delve more deeply into the origin and treatment of disease. The ultrahigh-field scanner, which will be used for human health studies in small animals, joins a 7T system purchased earlier this year.
Report from ASNR: CE-MRI identifies susceptibility to hemorrhage after stroke
May 2nd 2006Contrast-enhanced MRI reliably predicts whether acute stroke patients receiving intravenous tPA treatment are particularly susceptible to intracranial hemorrhage, according to a study presented Monday at the American Society of Neuroradiology meeting in San Diego.
MRI confirms effectiveness of b-thalassemia treatment
May 1st 2006British researchers have used T2* measures of cardiac iron loading to show the value of a new drug treatment for b-thalassemia, a genetic blood disorder. The laborious clinical trial involved transporting a mobile MRI system three times from London to the Mediterranean island of Sardinia.
Toshiba aspires to greater heights with advanced MR
May 1st 2006In cardiac catheterization, it's known as the money shot: coronaries floating in space with the shadow of the heart behind them. It is also the hardest shot to get, because of the amount of tissue that x-rays must penetrate. As patients get larger, the going gets tougher. But for MRI, capturing this shot has become a piece of cake.
CMR helps stratify risk for sudden cardiac death
May 1st 2006Physicians have yet to find a simple, inexpensive test to screen for the risk of sudden cardiac death. But they are learning how cardiac MR imaging may help stratify risk and guide treatment for conditions that can strike without warning.
Uncle's experience illustrates need for rapid response to ischemic stroke
May 1st 2006I have a personal interest in finding better ways of treating stroke. My favorite uncle was struck down by one in 1994, just as I was reporting on how the combination of tPA and head CT could produce miracles.
CMR extends influence to ventricular remodeling
May 1st 2006Figuring out how to treat postinfarction left ventricular remodeling using delayed-enhancement cardiac MR is not so cut and dried as it seems. Bright signal may signify dead myocardial tissue during DE-MR viability studies, but bright and dark myocardium both have stories to tell when dealing with remodeling.
Radiology can lead discussion of stroke therapy issues
May 1st 2006We have good news to report in this month's cover story: Research in stroke imaging is beginning to widen the window of time in which drug-based or mechanical therapy can be used to preserve brain function following an ischemic stroke. But we have bad news to report as well: More than a decade after research established the value of thrombolytic therapy to revascularize the brain and preserve brain tissue, the use of tissue plasminogen activator for stroke therapy remains stubbornly in the 2% range. Many victims go untreated for the nation's number three cause of death and a leading cause of serious long-term disability.
The window expands for more effective stroke treatment
May 1st 2006Buffalo psychologist Jamie Shiffner, Ph.D., beat the odds. The acute stroke patient was lucky enough to have everything go right after being struck down. With ischemic stroke, time is brain. Within moments of Shiffner's collapse at home on the evening of April 11, 2005, millions of neurons in his brain began dying every minute. The left side of Shiffner's body went numb, and attempts to talk resulted in nonsense phrases.
Study bolsters viability for MR of implanted devices
May 1st 2006MR imaging of pacemakers and implantable cardioverter devices is not for every imaging service. But the procedure is feasible, despite American College of Radiology recommendations to the contrary, according to a study from Oklahoma.
Dynamic contrast-enhanced MR imaging finally comes of age
May 1st 2006Tumors require new blood vessels in order to grow beyond a few millimeters in size. Once this "angiogenic switch" is thrown, a series of events occur that lead to the progression and spread of cancer. The vessels formed by tumors are not only larger and more numerous but also more permeable than normal vessels1 (Figure 1). Thus, when a patient with a tumor is injected with a gadolinium-chelate MR contrast agent, the tumor enhances more than the surrounding normal tissue.
MR arterial spin labeling proves feasible, safe in children
April 24th 2006High-field MR perfusion imaging with arterial spin labeling (ASL) can be performed safely and effectively on clinical pediatric populations for several neurological indications, according to Harvard University researchers.
Imaging tracks down brain’s oops! button
April 18th 2006We all make mistakes, and some cost more than others. Now, researchers have peered inside the brain to see what happens at the moment we realize our error -- and its price. Their findings may have implications for understanding obsessive-compulsive disorder.